These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 16957043)
1. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. Wang G; Hindler JF; Ward KW; Bruckner DA J Clin Microbiol; 2006 Nov; 44(11):3883-6. PubMed ID: 16957043 [TBL] [Abstract][Full Text] [Related]
2. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage. Alós JI; García-Cañas A; García-Hierro P; Rodríguez-Salvanés F J Antimicrob Chemother; 2008 Oct; 62(4):773-5. PubMed ID: 18552338 [TBL] [Abstract][Full Text] [Related]
3. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. Steinkraus G; White R; Friedrich L J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693 [TBL] [Abstract][Full Text] [Related]
4. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009. Hawser SP; Bouchillon SK; Hoban DJ; Dowzicky M; Babinchak T Int J Antimicrob Agents; 2011 Mar; 37(3):219-24. PubMed ID: 21239146 [TBL] [Abstract][Full Text] [Related]
5. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Sader HS; Fritsche TR; Jones RN Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409 [TBL] [Abstract][Full Text] [Related]
6. Vancomycin MIC susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates: a comparison between Etest® and an automated testing method. Bland CM; Porr WH; Davis KA; Mansell KB South Med J; 2010 Nov; 103(11):1124-8. PubMed ID: 20890258 [TBL] [Abstract][Full Text] [Related]
7. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates. Hussain FM; Boyle-Vavra S; Shete PB; Daum RS J Infect Dis; 2002 Sep; 186(5):661-7. PubMed ID: 12195353 [TBL] [Abstract][Full Text] [Related]
8. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Tenover FC; Moellering RC Clin Infect Dis; 2007 May; 44(9):1208-15. PubMed ID: 17407040 [TBL] [Abstract][Full Text] [Related]
9. Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program. Sader HS; Flamm RK; Farrell DJ; Jones RN Clin Infect Dis; 2012 Sep; 55 Suppl 3():S181-6. PubMed ID: 22903950 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010). Zhao C; Sun H; Wang H; Liu Y; Hu B; Yu Y; Sun Z; Chu Y; Cao B; Liao K; Lei J; Hu Z; Zhang L; Zhang X; Xu Y; Wang Z; Chen M Diagn Microbiol Infect Dis; 2012 Jun; 73(2):174-81. PubMed ID: 22521693 [TBL] [Abstract][Full Text] [Related]
11. Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia. Yeh YC; Yeh KM; Lin TY; Chiu SK; Yang YS; Wang YC; Lin JC J Microbiol Immunol Infect; 2012 Jun; 45(3):214-20. PubMed ID: 22571999 [TBL] [Abstract][Full Text] [Related]
12. Glycopeptide minimum inhibitory concentration creep among meticillin-resistant Staphylococcus aureus from 2006-2011 in China. Zhuo C; Xu YC; Xiao SN; Zhang GY; Zhong NS Int J Antimicrob Agents; 2013 Jun; 41(6):578-81. PubMed ID: 23562222 [TBL] [Abstract][Full Text] [Related]
13. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Hiramatsu K; Aritaka N; Hanaki H; Kawasaki S; Hosoda Y; Hori S; Fukuchi Y; Kobayashi I Lancet; 1997 Dec; 350(9092):1670-3. PubMed ID: 9400512 [TBL] [Abstract][Full Text] [Related]
14. Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada. Webster D; Rennie RP; Brosnikoff CL; Chui L; Brown C Diagn Microbiol Infect Dis; 2007 Feb; 57(2):177-81. PubMed ID: 16938420 [TBL] [Abstract][Full Text] [Related]
15. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999]. Nashev D; Toshkova K; Gavrilova V Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664 [TBL] [Abstract][Full Text] [Related]
16. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin]. Kotulová D; Slobodníková L Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years. Appleman MD; Citron DM Diagn Microbiol Infect Dis; 2010 Apr; 66(4):441-4. PubMed ID: 20226335 [TBL] [Abstract][Full Text] [Related]
18. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital. Sancak B; Ercis S; Menemenlioglu D; Colakoglu S; Hasçelik G J Antimicrob Chemother; 2005 Sep; 56(3):519-23. PubMed ID: 16046461 [TBL] [Abstract][Full Text] [Related]
19. Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital. Vaudaux P; Huggler E; Arhin FF; Moeck G; Renzoni A; Lew DP Int J Antimicrob Agents; 2009 Dec; 34(6):540-3. PubMed ID: 19744838 [TBL] [Abstract][Full Text] [Related]
20. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia. Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]